US Bancorp DE Buys 1,134 Shares of Privia Health Group, Inc. (NASDAQ:PRVA)

US Bancorp DE boosted its stake in shares of Privia Health Group, Inc. (NASDAQ:PRVA) by 6.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 18,058 shares of the company’s stock after acquiring an additional 1,134 shares during the quarter. US Bancorp DE’s holdings in Privia Health Group were worth $353,000 as of its most recent SEC filing.

Several other large investors also recently added to or reduced their stakes in PRVA. Riverbridge Partners LLC increased its stake in Privia Health Group by 19.7% during the fourth quarter. Riverbridge Partners LLC now owns 5,824,458 shares of the company’s stock worth $113,868,000 after acquiring an additional 958,418 shares during the last quarter. Eventide Asset Management LLC increased its stake in Privia Health Group by 979.2% during the third quarter. Eventide Asset Management LLC now owns 822,438 shares of the company’s stock worth $14,977,000 after acquiring an additional 746,231 shares during the last quarter. Icon Wealth Advisors LLC increased its stake in Privia Health Group by 1,910.1% during the third quarter. Icon Wealth Advisors LLC now owns 300,889 shares of the company’s stock worth $5,479,000 after acquiring an additional 285,920 shares during the last quarter. FMR LLC grew its stake in shares of Privia Health Group by 1.5% during the third quarter. FMR LLC now owns 18,169,043 shares of the company’s stock valued at $330,858,000 after buying an additional 271,645 shares during the last quarter. Finally, Barclays PLC grew its stake in shares of Privia Health Group by 240.3% during the third quarter. Barclays PLC now owns 224,018 shares of the company’s stock valued at $4,079,000 after buying an additional 158,188 shares during the last quarter. 94.48% of the stock is owned by institutional investors.

Privia Health Group Trading Down 2.7 %

Shares of NASDAQ PRVA opened at $23.38 on Friday. The stock has a market capitalization of $2.82 billion, a PE ratio of 233.82, a price-to-earnings-growth ratio of 3.47 and a beta of 0.85. The stock’s fifty day simple moving average is $23.29 and its two-hundred day simple moving average is $20.89. Privia Health Group, Inc. has a 12-month low of $15.92 and a 12-month high of $26.04.

Analysts Set New Price Targets

PRVA has been the topic of several recent analyst reports. Stephens reiterated an “overweight” rating and issued a $26.00 price target on shares of Privia Health Group in a report on Thursday, January 2nd. JMP Securities set a $29.00 price target on Privia Health Group in a report on Friday, February 28th. JPMorgan Chase & Co. increased their price target on Privia Health Group from $27.00 to $28.00 and gave the stock an “overweight” rating in a report on Friday, November 29th. Macquarie initiated coverage on Privia Health Group in a report on Monday, December 16th. They issued an “outperform” rating and a $25.00 price target on the stock. Finally, Piper Sandler increased their price target on Privia Health Group from $25.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, February 28th. One analyst has rated the stock with a hold rating, thirteen have issued a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Buy” and a consensus price target of $26.67.

Privia Health Group Profile

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.